About this trial
The goal of this observational study is to describe speech and breathing patterns in adults after acquired brain injury (ABI) and understand how these patterns relate to the presence, severity, and type of dysarthria. The main questions it aims to answer are:
* What changes in voice and breathing are observed in adults with dysarthria after ABI? * Can combining acoustic, respiratory, and clinical assessments help identify dysarthria severity and subtype?
Participants will:
* Have their speech recorded to measure voice and articulation features, such as pitch, clarity, and the ability to sustain sounds. * Perform breathing tests using a spirometer to assess lung function. * Complete the Frenchay Dysarthria Assessment-2 (FDA-2), adapted to Spanish, to classify dysarthria type and severity.
About 97 to 101 participants will take part. The results will help speech therapists better detect, evaluate, and treat dysarthria in adults after brain injury.
Eligibility criteria
Qualifiers
Adults aged 18 years or older at the time of enrollment.
Stroke
Traumatic brain injury (TBI)
Brain tumor
Disqualifiers
History of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) or asthma.
History of hearing impairments that could affect speech evaluation.
Presence of additional neurological or neurodegenerative disorders other than the acquired brain injury.
History of voice disorders or dysphonia prior to the acquired brain injury.
Trial design
Treatments tested in this trial
- Not listed